Interferon Alpha-2b (Intron A) for Metastatic or Unresectable Clear Cell Renal Carcinoma

NCT00293527 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Withdrawn in October 2006, no longer of interest

Conditions

Renal Cancer

Interventions

DRUG: Interferon Alpha-2b

Sponsor

Ohio State University Comprehensive Cancer Center